Sarcoptes scabiei var. canis refractory to ivermectin treatment in two dogs

Veterinary Dermatology

Volumn 21, Issue 6, 2010, Pages 608-612

  Terada, Yuri ^a   Murayama, Nobuo ^a   Ikemura, Hiroshi ^b   Morita, Tatsushi ^c   Nagata, Masahiko ^a  

^a ASC   (Japan)

^b Ikemura Pet Clinic   (Japan)

^c NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT; FIPRONIL; IVERMECTIN; PYRAZOLE DERIVATIVE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CASE REPORT; DOG; DOG DISEASE; DRUG EFFECT; DRUG RESISTANCE; MALE; PARASITOLOGY; SARCOPTES SCABIEI; SCABIES;

ANIMALS; ANTIPARASITIC AGENTS; DOG DISEASES; DOGS; DRUG RESISTANCE; IVERMECTIN; MALE; PYRAZOLES; SARCOPTES SCABIEI; SCABIES;

ACARI; CANIS; CANIS FAMILIARIS; SARCOPTES SCABIEI;

EID: 78349280006     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2010.00895.x     Document Type: Article

References (23)

1. Scott DW, Miller WH, Griffin CE. Canine scabies. In: Muller and Kirk's Small Animal Dermatology, 6th edn. Philadelphia, PA: W. B. Saunders Co., 2001: 476-83.
2. Arlian LG, Vyszenski-Moher DL. Life cycle of Sarcoptes scabiei var. canis. The Journal of Parasitology 1988; 74: 427-30.
3. Griffin CE, Kwochka KW, Macdonald JM. Scabies. In: Current Veterinary Dermatology. Missouri: Mosby Year Book, 1993: 85-9.
4. Medleau L, Hnilica KA. Canine scabies. In: Small Animal Dermatology: A Color Atlas and Therapeutic Guide, 2nd edn. Philadelphia, PA: W. B. Saunders Co., 2006: 112-4.
5. Curtis CF. Use of 0.25 per cent fipronil spray to treat sarcoptic mange in a litter of five-week-old puppies. Veterinary Record 1996; 139: 43-4.
6. Roulet A, Puel O, Gesta S et al. MDR1-deficient genotype in Collie dogs hypersensitive to the P-glucoprotein substrate ivermectin. European Journal of Pharmacology 2003; 460: 85-91.
7. Shoop WL. Ivermectin resistance. Parasitology Today 1993; 9: 154-9.
8. Xu M, Molento M, Blackhall W et al. Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog. Molecular and Biochemical Parasitology 1998; 91: 327-35.
9. Burkhart CN. Ivermectin: an assessment of its pharmacology, microbiology and safety. Veterinary and Human Toxicology 2000; 42: 30-5.
10. Chosidow O. Scabies and pediculosis. Lancet 2000; 355: 819-26.
11. Scheidt VJ, Medleau L, Seward RL et al. An evaluation of ivermectin in the treatment of sarcoptic mange in dogs. American Journal of Veterinary Research 1984; 45: 1201-2.
12. Alva-Valdes R, Wallace DH, Benz GW et al. Efficacy of ivermectin against the mange mite Sarcoptes scabiei var. suis in pigs. American Journal of Veterinary Research 1984; 45: 2113-4.
13. Gokbulut C, Karademir U, Boyacioglu M et al. Comparative plasma disposition of ivermectin and doramectin following subcutaneous and oral administration in dogs. Veterinary Parasitology 2006; 135: 347-54.
14. Yazwinski TA, Pote L, Tilley W et al. Efficacy of ivermectin against Sarcoptes scabiei and Otodectes cynotis infestations of dogs. Veterinary Medicine Small Animal Clinician 1981; 76: 1749-51.
15. Executive committee of guideline for the diagnosis and treatment of scabies. Guideline for the diagnosis and treatment of scabies. The Japanese Journal of Dermatology 2007; 117: 1-13.
16. Currie BJ, Harumal P, McKinnon M et al. First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. Clinical Infectious Disease 2004; 39: 8-12.
17. Van den Hoek JA, Van de Weerd JA, Baayen TD et al. A persistent problem with scabies in and outside a nursing home in Amsterdam: indications for resistance to lindane and ivermectin. Eurosurveillance 2008; 13: Available at: Accessed April 15 2009.
18. Stoneham S, Coles G. Ivermectin resistance in Parascaris equorum. Veterinary Record 2006; 158: 572.
19. Byford RL, Craig ME, Derouen SM et al. Influence of permethrin, diazinon and ivermectin treatments on insecticide resistance in the horn fly (Diptera: Muscidae). International Journal for Parasitology 1999; 29: 125-35.
20. Kane NS, Hirschberg B, Qian S et al. Drug-resistant Drosophila indicate glutamate-gated chloride channels are targets for the antiparasitics nodulisporic acid and ivermectin. Proceedings of the National Academy of Sciences of the United States of America 2000; 97: 13949-54.
21. Benavides E, Romero A. Preliminary results of a larval resistance test to ivermectins using Boophilus microplus reference strains. Annals of the New York Academy of Sciences 2000; 916: 610-2.
22. Reed MB, Saliba KJ, Caruana SR et al. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 2000; 403: 906-9.
23. Prichard R. Genetic variability following selection of Haemonchus contortus with anthelmintics. Trends in Parasitology 2001; 17: 445-53.